Cataract Extraction: Clinical Trials

4 trials for Cataract Extraction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Recruiting 1

Follow Cataract Extraction: new trials by email Literature Review of Cataract Extraction trials Research Report on Cataract Extraction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRO-232 in Patients Subjected to Cataract Surgery
Moxifloxacin / Dexamethasone Ophthalmic Solution, Placebo, Moxifloxacin Hydrochloride, Ophthalmic - Cataract Extraction
Phase 3RecruitingLaboratorios Sophia S.A de C.V.1342025-10-272025-12-26
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
NETILDEX™ ophthalmic gel, NETILDEX™ eye drops solution - Cataract Extraction, Cataract
Phase 3CompletedSIFI SpA1802017-10-152019-01-14
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
ketorolac eye drops - Cataract Extraction
Phase 3CompletedAllergan2632007-10-012009-10-01
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
ketorolac - Cataract Extraction, Pain
Phase 3CompletedAllergan2482007-10-012009-10-01

Narrower conditions

Cataract (1)  ·  Inflammation (1)  ·  Pain (1)

Broader conditions

Eye Diseases (1)  ·  Lens Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Ketorolac (1)  ·  Moxifloxacin (1)  ·  Vision, Ocular (1)  ·  dexamethasone 21-phosphate (1)

Sponsors

Allergan (2)  ·  Laboratorios Sophia S.A de C.V. (1)  ·  SIFI SpA (1)

Countries

United States (2)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Romania (1)

Top investigators

Aldo Caporossi, MD, Prof. (1)

Results publications

PMID 21145532

NIH funding

2016 (1)